MEN1 and breast cancer: The growth inhibitory effects of EPZ and MEN1, either alone or in combination, are accompanied by down-regulation of ERα expression (Fig. 2J–L), an effect that is likely to contribute to the antiproliferative effects of these compounds in estrogen-responsive BC cells [8, 48].